Organization Overview
Historical Acquisition Tree
Alternative names
Key: The EMMES Corporation (20) Acquired (1)
bevacizumab (avastin) (2 trials)
clindamycin (cleocin) (2 trials)
clopidogrel (plavix) (1 trial)
fluorouracil (efudex) (3 trials)
human papillomavirus quadrivalent (types 6, 11, 16 and 18) vaccine, recombinant (Gardasil) (4 trials)
Key: The EMMES Corporation (54) Acquired (1)
allogeneic adipose derived mesenchymal stem cell (4 trials)
autologous cd34+ cells (1 trial)
autologous mesenchymal stem cells (3 trials)
bupropion (wellbutrin) (1 trial)
carboplatin (paraplatin) (3 trials)
ciliary neurotrophic factor (2 trials)
cisplatin (platinol) (3 trials)
cytarabine (cytosar-u) (1 trial)
daclizumab (Zenapax) (1 trial)
dextromethorphan (delsym) (1 trial)
doxorubicin (Doxil) (4 trials)
ephb4-hsa fusion protein (1 trial)
etoposide (vepesid) (4 trials)
Filgrastim (neupogen) (2 trials)
finasteride (Proscar) (1 trial)
lidocaine (xylocaine) (1 trial)
minocycline (minocin) (2 trials)
nelfinavir (viracept) (1 trial)
nitric oxide (inomax) (1 trial)
parathyroid hormone (Natpara) (1 trial)
prednisone (meticorten) (3 trials)
allogeneic hematopoietic stem cells (Hemacord) (1 trial)
aluminum hydroxide (Gaviscon) (1 trial)
daratumumab (darzalex) (1 trial)
daunorubicin (cerubidine) (1 trial)
gp145 c.6980 vaccine (1 trial)
inactivated influenza vaccine (1 trial)
lisinopril (zestril) (1 trial)
live oral poliovirus type 1, 2 and 3 (Trivalent oral polio vaccine - Sabin) (1 trial)
monovalent oral polio vaccines (mopv1) (MOPV1) (1 trial)
novel oral polio vaccine type 1 (nopv1) (1 trial)
novel oral polio vaccine type 3 (nopv3) (1 trial)
Acquired Immunodeficiency Syndrome (Phase 2)
Adenoviridae Infections (Phase 2)
Alphavirus Infections (Phase 1)
Anemia, Aplastic (Phase 2)
Anus Neoplasms (Phase 3)
Arthritis (Phase 2)
Arthritis, Juvenile (Phase 2)
Atrophy (Phase 2)
Autism Spectrum Disorder (Phase 2)
Autistic Disorder (Phase 2)
Bacterial Infections (Phase 1)
Breast Neoplasms (Phase 1)
Bronchopulmonary Dysplasia (Phase 2)
Burkitt Lymphoma (Phase 2)
Carcinoma (Phase 1)
Carcinoma in Situ (Phase 2)
Carcinoma, Non-Small-Cell Lung (Phase 1)
Carcinoma, Ovarian Epithelial (Phase 1)
Carcinoma, Squamous Cell (Phase 1)
Carcinoma, Verrucous (Phase 1)
Central Serous Chorioretinopathy (Phase 2)
Chikungunya Fever (Phase 2)
Child Development Disorders, Pervasive (Phase 2)
Cocaine-Related Disorders (Phase 3)
Communicable Diseases (Phase 3)
Coronavirus Infections (Phase 2)
Critical Illness (Phase 3)
Cryptosporidiosis (Phase 2)
Depression (Phase 2)
Depressive Disorder (Phase 2)
Depressive Disorder, Major (Phase 2)
Diabetes Mellitus, Type 1 (Phase 3)
Disease (Phase 3)
Edema (Phase 4)
Emergencies (Phase 2)
Encephalitis (Phase 1)
Encephalomyelitis, Eastern Equine (Phase 1)
Encephalomyelitis, Equine (Phase 1)
Encephalomyelitis, Venezuelan Equine (Phase 1)
Encephalomyelitis, Western Equine (Phase 1)
Enterocolitis (Phase 2)
Enterocolitis, Necrotizing (Phase 2)
Epstein-Barr Virus Infections (Phase 2)
Esophageal Neoplasms (Phase 1)
Fibrosis (Phase 1)
Flaviviridae Infections (Phase 2)
Flavivirus Infections (Phase 2)
Frailty (Phase 2)
Gastroesophageal Reflux (Phase 1)
Geographic Atrophy (Phase 2)
Graft vs Host Disease (Phase 2)
Heart Failure (Phase 2)
Hemangioma (Phase 2)
Hemangioma, Capillary (Phase 2)
Hemorrhagic Fever, Ebola (Phase 1)
Hemorrhagic Fevers, Viral (Phase 1)
HIV Infections (Phase 3)
Hodgkin Disease (Phase 2)
Hypertension (Phase 1)
Hypertension, Pulmonary (Phase 1)
Idiopathic Pulmonary Fibrosis (Phase 1)
Immunologic Deficiency Syndromes (Phase 2)
Infarction (Phase 2)
Infections (Phase 3)
Influenza, Human (Phase 1)
Intraabdominal Infections (Phase 3)
Iridocyclitis (Phase 2)
Iritis (Phase 2)
Ischemia (Phase 3)
Ischemic Attack, Transient (Phase 3)
Laryngeal Diseases (Phase 1)
Laryngeal Neoplasms (Phase 1)
Leukemia (Phase 2)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)
Leukemia, Lymphoid (Phase 2)
Leukemia, Myeloid (Phase 2)
Leukemia, Myeloid, Acute (Phase 2)
Lung Neoplasms (Phase 1)
Lymphoma (Phase 2)
Lymphoma, AIDS-Related (Phase 2)
Lymphoma, B-Cell (Phase 2)
Lymphoma, Large B-Cell, Diffuse (Phase 2)
Lymphoma, Large-Cell, Immunoblastic (Phase 2)
Lymphoma, Non-Hodgkin (Phase 2)
Macular Edema (Phase 4)
Migraine Disorders (Phase 3)
Myocardial Infarction (Phase 2)
Nasopharyngeal Carcinoma (Phase 1)
Neonatal Abstinence Syndrome (Phase 3)
Neoplasms (Phase 2)
Opioid-Related Disorders (Phase 3)
Oropharyngeal Neoplasms (Phase 1)
Papilloma (Phase 3)
Papillomavirus Infections (Phase 3)
Paranasal Sinus Neoplasms (Phase 1)
Parasomnias (Phase 2)
Penile Neoplasms (Phase 2)
Persistent Fetal Circulation Syndrome (Phase 1)
Plasmablastic Lymphoma (Phase 2)
Poliomyelitis (Phase 1)
Port-Wine Stain (Phase 2)
Precancerous Conditions (Phase 2)
Premature Birth (Phase 1)
Pulmonary Fibrosis (Phase 1)
Retinal Diseases (Phase 2)
Retinal Vein Occlusion (Phase 3)
Retinitis (Phase 2)
Retinitis Pigmentosa (Phase 2)
RNA Virus Infections (Phase 2)
Salivary Gland Neoplasms (Phase 1)
Sarcoma (Phase 2)
Sarcoma, Kaposi (Phase 2)
Sepsis (Phase 1)
Severe Acute Respiratory Syndrome (Phase 2)
Sleep Wake Disorders (Phase 2)
Status Epilepticus (Phase 1)
Stomach Neoplasms (Phase 1)
Substance-Related Disorders (Phase 4)
Substance Withdrawal Syndrome (Phase 3)
Syndrome (Phase 3)
Telangiectasis (Phase 2)
Uterine Cervical Neoplasms (Phase 3)
Uveitis (Phase 2)
Uveitis, Anterior (Phase 2)
Ventricular Dysfunction (Phase 2)
Ventricular Dysfunction, Left (Phase 2)
Virus Diseases (Phase 3)
Zika Virus Infection (Phase 2)